Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Paper talk: One step closer to new stroke treatment; breast cancer screening claims dubbed "dishonest"

Media Watch Could a new stem cell trial pave the way for new stroke treatment? What are the real facts behind the NHS Breast Screening Programme's claims?

The world's first clinical trial of brain stem cells has passed its first safety test, paving the way for new stroke treatments, the BBC reports.

Claims by the NHS Breast Screening Programme that screening cuts breast cancer by a third have been described as dishonest by critics, the Independent reports.

A Lords committee has called for a new initiative that will help minimise the spread of HIV in the UK, the Independent reports. The BBC also covers this story.

The Guardian reports that HIV awareness has fallen under the radar despite detection rates doubling since 1990.

Women who have abortions face nearly twice the risk of mental health problems compared with others, the Telegraph reports.  The Daily Mail also covers this story.

The Telegraph reports that Prime Minister David Cameron will next week oppose plans to offer women considering an abortion independent counselling.

Former NHS chief executive Lord Crisp says that more hospitals are going to have to close if the NHS is going to cope in the future, the BBC reports.

Women's groups are pushing for US health regulators to remove Johnson & Johnson's silicone breast implants from the market, the Daily Mail reports.

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD014471

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel